Techniclone (TCLN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Maurice Winn who wrote (2653)	11/7/1998 8:38:00 PM
From: Jibacoa	Read Replies (2) of 3702

Maurice:Here is a chance to put your 10 points theory of "Advantages of Reverse Split" to a test. Buy Cytel (CYTL) presently around $0.50 to $0.60. They just announced a one for seven reverse split. That will bring the number of shares down to 5 million. They still have a majority ownership of Epimmune which just received INH funds for they research on vaccine for hepatitis-C. Also working with Monsanto's Searle on a cancer vaccine. In the mean time TCLN has bounced back from October's 9th and 13th lows of $0.63 and yesterday's close of $1.09 brought the price above the 40 day average line (now at 1.00) If we can overcome the resistance at $1.30- $1.60 level we should be testing September's 15th high of $2.00.Even without a reverse split!! The chart is starting to look better.(By the way yesterday's price was also just above the 25 week average line.) Good luck to all. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next